Fatal liver failure in haemophiliacs with HIV-induced immunodeficiency: observation of six patients.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 109, doi. 10.1046/j.1365-2516.1999.00281.x
- By:
- Publication type:
- Article
Works matching IS 13518216 AND DT 1999 AND VI 5 AND IP 2
Results: 14
1
2
Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 88, doi. 10.1046/j.1365-2516.1999.00282.x
- By:
- Publication type:
- Article
3
The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 106, doi. 10.1046/j.1365-2516.1999.00283.x
- By:
- Publication type:
- Article
4
Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 96, doi. 10.1046/j.1365-2516.1999.00284.x
- By:
- Publication type:
- Article
5
A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 115, doi. 10.1046/j.1365-2516.1999.00287.x
- By:
- Publication type:
- Article
6
Counselling about diagnosis and inheritance of genetic bleeding disorders: haemophilia A and B.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 77, doi. 10.1046/j.1365-2516.1999.00288.x
- By:
- Publication type:
- Article
7
Emotional reactions of haemophilia health care providers.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 127, doi. 10.1046/j.1365-2516.1999.t01-1-00289.x
- By:
- Publication type:
- Article
8
Does avascular necrosis cause collapse of the dome of the talus in severe haemophilia?
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 139, doi. 10.1046/j.1365-2516.1999.00291.x
- By:
- Publication type:
- Article
9
Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 124, doi. 10.1046/j.1365-2516.1999.00292.x
- By:
- Publication type:
- Article
10
Anaphylaxis following the use of a plasma-derived immunopurified Monoclate-P®, and the recombinant Recombinate® and Kogenate® factor VIII: a therapeutic challenge.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 143, doi. 10.1046/j.1365-2516.1999.00293.x
- By:
- Publication type:
- Article
11
Postoperative use of rFVIIa by continuous infusion in a haemophilic boy.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 135, doi. 10.1046/j.1365-2516.1999.t01-2-00294.x
- By:
- Publication type:
- Article
12
Prenatal diagnosis of haemophilia.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 84, doi. 10.1046/j.1365-2516.1999.00295.x
- By:
- Publication type:
- Article
13
Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 132, doi. 10.1046/j.1365-2516.1999.00297.x
- By:
- Publication type:
- Article
14
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
- Published in:
- Haemophilia, 1999, v. 5, n. 2, p. 101, doi. 10.1046/j.1365-2516.1999.00303.x
- By:
- Publication type:
- Article